External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

AHA 2026

-
Coming soon
07:45 PM
Duration 75mins Chicago, USA
Changes in Cardiovascular Prognostic Markers of Central and Visceral Adiposity in Older and Younger Adults Living With Obesity/Overweight With ≥1 Weight-Related Comorbidity in a Phase 2 Trial of Enicepatide, a GLP-1/GIP Receptor Agonist
Odd Erik Johansen, Nikolaus Marx, Javed Butler, Helen M. Colhoun, Xuwei Hou, Julie H. Ishida, Macy Gipson, Ji (Emmy) Cheng

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar